LiDCO the cardiovascular monitoring company is pleased to announce that it is holding an open day for investors and analysts to be held at St Thomas’ hospital, London, on Monday 9 October, from 2pm until 5pm.

The purpose of the afternoon is to brief the City audience on LiDCO’s R&D strategy including details of the latest software release (Version 4) and the new research and clinical audit product LiDCOview. Version 4, in combination with the LiDCOview will demonstrate how our technology has made a significant leap forward compared with the market’s current older, non-PC based measuring devices.

The Company will also be showing investors the new URINFO™ system from Med-Dynamix with whom LiDCO have recently signed an exclusive agreement to distribute in the UK and Ireland.

Brief talks will be given by clinicians and nurses who are using the technology as well as by the Company to demonstrate both the business and clinical case for our technology and how it has enhanced patient outcomes and saved lives.

No financial information will be provided during the open day.

Analysts, investors and potential investors are very welcome and should you wish to attend please call the Company Secretary; details below.

LiDCO’s interim results and investor presentation LiDCO’s Interim Results – six months ended 31st July 2006 will be available on the LiDCO website (www.lidco.com) on the 18th October 2006.

Notes to Editors

About LiDCO Group Plc
LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO’s technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery.  The technology was invented in the Department of Applied Physiology based at St Thomas’ Hospital, London.

The Company’s manufacturing facility is in London N1, UK and its products are:

• LiDCOplus and PulseCO monitors: computer-based platforms for displaying and management of a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;
  
  
• LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

Distribution Network:
The Company has now achieved registration of its products in 14 markets in Europe, together with the USA, Brazil and Japan.  It sells direct in the USA and UK, and elsewhere through a worldwide network of specialty critical care distributors.